相关实验视频

Updated: Jun 17, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

在非小细胞肺癌中,TFEB控制了对化疗和免疫杀伤的敏感性

Muhlis Akman1, Ciro Monteleone1, Gabriella Doronzo1,2

  • 1Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.

Journal of experimental & clinical cancer research : CR
|August 6, 2024
PubMed
概括

转录因子EB (TFEB) 调节药物排放载体ABCC1和ABCA1,影响非小细胞肺癌 (NSCLC) 化学免疫治疗反应. 佐勒多尼酸通过调节新陈代谢和免疫微环境来重新敏感TFEB低的NSCLC.

关键词:
在ABCA1中,ABCA1是ABCA1.ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1ABCC1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1C1化学免疫耐药性 化学免疫耐药性非小细胞肺癌是非小细胞肺癌.美国联邦税务法 (TFEB)Vγ9Vδ2 T 淋巴细胞

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.5K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

308

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K